➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Dow
Colorcon
Johnson and Johnson
McKinsey
Medtronic
AstraZeneca

Last Updated: July 29, 2021

DrugPatentWatch Database Preview

Miglitol - Generic Drug Details

➤ Get the DrugPatentWatch Daily Briefing

« Back to Dashboard

What are the generic drug sources for miglitol and what is the scope of patent protection?

Miglitol is the generic ingredient in two branded drugs marketed by Pfizer and Orient Pharma Co Ltd, and is included in two NDAs. Additional information is available in the individual branded drug profile pages.

There is one drug master file entry for miglitol. Three suppliers are listed for this compound.

Drug Prices for miglitol

See drug prices for miglitol

Recent Clinical Trials for miglitol

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Canadian Network for Observational Drug Effect Studies, CNODESN/A
Canadian Institutes of Health Research (CIHR)N/A
Drug Safety and Effectiveness Network, CanadaN/A

See all miglitol clinical trials

Pharmacology for miglitol

US Patents and Regulatory Information for miglitol

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Orient Pharma Co Ltd MIGLITOL miglitol TABLET;ORAL 203965-002 Feb 24, 2015 AB RX No No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
Pfizer GLYSET miglitol TABLET;ORAL 020682-002 Dec 18, 1996 AB RX Yes No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
Orient Pharma Co Ltd MIGLITOL miglitol TABLET;ORAL 203965-003 Feb 24, 2015 AB RX No No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for miglitol

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Pfizer GLYSET miglitol TABLET;ORAL 020682-001 Dec 18, 1996 ⤷  Try it Free ⤷  Try it Free
Pfizer GLYSET miglitol TABLET;ORAL 020682-003 Dec 18, 1996 ⤷  Try it Free ⤷  Try it Free
Pfizer GLYSET miglitol TABLET;ORAL 020682-002 Dec 18, 1996 ⤷  Try it Free ⤷  Try it Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
Colorcon
Johnson and Johnson
McKinsey
Medtronic
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.